Antimicrobial Resistance: A Growing Threat Claiming Millions of Lives Globally
Table of Contents
A concerning rise in antimicrobial resistance (AMR) contributed to approximately 4.7 million deaths worldwide in 2021, including 35,000 in Europe and 4,000 in Spain, underscoring a critical public health crisis demanding immediate attention.
The escalating challenge of AMR was highlighted during World Awareness Week on Antimicrobial Resistance, prompting the Spanish Association of Bioenterprises (Asebio) to convene a discussion with MSD focused on “Biotechnology for a safer future.” Asebio’s CEO emphasized that antimicrobial resistance “are a challenge that impacts society, health, economy and health systems.”
The Role of Biotechnology in Combating Resistance
Biotechnology is emerging as a crucial tool in the fight against AMR,offering the potential for rapid and affordable diagnostic solutions. This perspective was echoed by a leading expert at the Complutense University of Madrid, who stressed the importance of a holistic approach to tackling the issue.
“It is absurd to focus on human health without focusing on other elements,” the expert stated, advocating for the “One Health” concept – recognizing the interconnectedness of microorganisms between humans and animals. This approach acknowledges that addressing AMR requires a collaborative effort across disciplines and sectors.
Declining Antibiotic development Pipeline
A particularly alarming trend is the dwindling number of new antibiotics in development. While 97 potential antibiotics were in the pipeline in 2023, projections indicate this number will decrease to 90 by 2025.Of these,only 40 are targeted at non-conventional microorganisms,and a mere 15 explore innovative mechanisms of action.
This decline is largely attributed to economic factors. According to one analyst, “It is not a profitable line of research,” leading smaller biotechnology companies to shoulder the majority of the burden in seeking new targets. There is a growing call to incentivize larger pharmaceutical companies to re-engage in antibiotic development to address this critical public health need.
Spain Faces Rising Antibiotic Usage
Spain is experiencing a notable increase in the use of last-resort antibiotics, mirroring a global trend. data reveals that 23.3% of patients receive at least one antibiotic prescription annually, averaging 1.8 treatments per patient. This overuse contributes to the development and spread of resistance, further complicating treatment options.
hope on the Horizon: Vaccines and Prevention
Despite the grim outlook, there is reason for optimism. New vaccines in development are expected to significantly reduce deaths associated with antimicrobial resistance, particularly within the pediatric population. Experts estimate that vaccines could reduce antibiotic use by as much as 22%.
Prevention remains paramount. Improving public awareness regarding responsible antibiotic use is crucial, including reducing self-medication. Moreover, proper disposal of unused medications, particularly antibiotics, through designated recycling points like Sigre, is essential to prevent environmental contamination and the further development of resistance.
A shift in cultural attitudes towards antibiotic prescriptions is also needed. As one expert noted, “You have to be happy when you are not prescribed an antibiotic; It is better for the microbiota and you do not generate resistance, among others.” This highlights the importance of viewing antibiotics as a precious resource to be used judiciously.
The current heightened attention on antimicrobial resistance presents a critical opportunity to prioritize this issue and implement immediate, effective solutions. The fu
